Insider Transactions in Q4 2022 at Lixte Biotechnology Holdings, Inc. (LIXT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Baan Bastiaan Jeroen Van Der President, CEO & Vice Chairman |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$40,000
$4.9 P/Share
|
|
Dec 15
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
15,000
+9.09%
|
$0
$0.51 P/Share
|
|
Dec 12
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.9%
|
$0
$0.61 P/Share
|
|
Dec 09
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
16,112
+4.41%
|
$0
$0.62 P/Share
|
|
Nov 22
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
2,484
+2.38%
|
$0
$0.56 P/Share
|
|
Nov 21
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
1,457
+1.44%
|
$0
$0.56 P/Share
|
|
Nov 21
2022
|
Regina Brown Director |
BUY
Open market or private purchase
|
Direct |
5,000
+34.28%
|
$0
$0.58 P/Share
|
|
Nov 18
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
16,207
+5.44%
|
$0
$0.56 P/Share
|
|
Nov 17
2022
|
Eric Forman Vice President and COO |
BUY
Open market or private purchase
|
Indirect |
4,852
+5.59%
|
$0
$0.54 P/Share
|
|
Nov 14
2022
|
Rene Bernards Director |
BUY
Open market or private purchase
|
Direct |
52,500
+29.58%
|
$0
$0.53 P/Share
|